Skip to content
Catalyst

(4S)-4-hydroxy-L-isoleucineFinding

(4S)-4-hydroxy-L-isoleucine decreases tumour necrosis factor alpha concentration

lowersInsufficient evidenceFinding

01 · The sentence it was drawn from

“In addition, inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα), were assessed, and their serum and testis concentrations were found to be reduced in 4-HIL treated mice compared to those in HFD mice (Supplementary Figures S2C, D).”
Quoted verbatim from Potential role of 4-hydroxyisoleucine in enhancing fertility in male mice with diet-induced obesity.
This finding among the 76 findings on its endpoint

(4S)-4-hydroxy-L-isoleucine

Tumour necrosis factor alpha concentration

lowers

Who
male C57BL/6 mice with high-fat-diet-induced obesity, high-fat diet continued in both arms
Dose studied
4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection for six weeks; control HFD mice received saline injections

Insufficient evidencePMID 40917356 · 2025

02 · The study

Study
animal · not in humans
Duration
6 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EX6QB2H9XQ20STMDW3D93P